• US green light for AZ’ Lokelma pharmatimes
    May 24, 2018
    The treatment, an insoluble, non-absorbed compound with a structure that was designed to preferentially capture potassium ions, was previously rejected by twice by the regulator largely because of manufacturing issues.
PharmaSources Customer Service